TRPV4 Antagonism Prevents Mechanically Induced Myotonia-Reference-Cited by-同舟云学术

TRPV4 Antagonism Prevents Mechanically Induced Myotonia

Published:2020-06-22 Issue:2 Volume:88 Page:297-308
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol

Author:

Dupont Chris¹,Novak Kevin¹,Denman Kirsten¹,Myers Jessica H.¹,Sullivan Jeremy M.²,Walker Phillip V.¹,Brown Nicklaus L.¹,Ladle David R.¹,Bogdanik Laurent³,Lutz Cathleen M.³,Voss Andrew⁴,Sumner Charlotte J.²⁵,Rich Mark M.¹^ORCID

Affiliation:

1. Department of Neuroscience, Cell Biology and Physiology Wright State University Dayton OH USA

2. Department of Neurology Johns Hopkins University School of Medicine Baltimore MD USA

3. The Jackson Laboratory Bar Harbor ME USA

4. Department of Biology Wright State University Dayton OH USA

5. Department of Neuroscience Johns Hopkins University School of Medicine Baltimore MD USA

Funder

Center for Scientific Review

Muscular Dystrophy Association

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ana.25780

Reference56 articles.

1. Non-dystrophic myotonia: prospective study of objective and patient reported outcomes

2. Channelopathies of Skeletal Muscle Excitability

3. Myotonic Dystrophy

4. Sodium Channelopathies of Skeletal Muscle

5. Mexiletine for Symptoms and Signs of Myotonia in Nondystrophic Myotonia

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gain-of-function mutations of TRPV4 acting in endothelial cells drive blood-CNS barrier breakdown and motor neuron degeneration in mice;Science Translational Medicine;2024-05-22

2. LIPUS regulates the progression of knee osteoarthritis in mice through primary cilia-mediated TRPV4 channels;Apoptosis;2024-03-22

3. Plateau potentials contribute to myotonia in mouse models of myotonia congenita;Experimental Neurology;2023-03

4. Multiubiquitination of TRPV4 reduces channel activity independent of surface localization;Journal of Biological Chemistry;2022-04

5. Current Treatment Options for Patients with Myotonic Dystrophy Type 2;Current Treatment Options in Neurology;2021-09